Medication Recall: Manufacturer Warns of Contamination

Overview of the recall

In 2026 a manufacturer issued a medication recall for certain batches of folic acid 5 mg tablets (PZN 18293103, pack size N3) after an abnormal result was found for the specification parameter described as an ‘impurity’ or contamination. Pharmacies were asked to review their stock and return affected packs to the pharmaceutical wholesaler by 19 February 2026. According to the manufacturer, there is no immediate patient risk from the affected product.

This notice is a routine safety step to ensure quality and protect patients. Medication recalls and recall notices are part of ongoing quality control in the pharmaceutical supply chain and do not always mean that a product has caused harm.

Which batches are affected and how to check

How to identify affected packs

Only specific batches of folic acid 5 mg tablets are included in this recall. To check whether you have an affected pack, compare the lot or batch number printed on your package with the recall information provided by your pharmacy or wholesaler. Also confirm the product identifier (PZN 18293103) and the pack size (N3).

• Locate the lot/lot number (sometimes called batch number) on the outer box or blister card.
• Check the product code: PZN 18293103 and pack size N3.
• If you are unsure whether a pack is affected, contact the dispensing pharmacy or return the pack to the pharmacy for verification.

What pharmacies were asked to do

Pharmacies were instructed to check their inventories for the listed batches and to return any affected packs to the pharmaceutical wholesaler by the deadline (19 February 2026). These steps help remove potentially non‑conforming product from the supply chain quickly.

1. Identify and isolate any packs with matching batch numbers.
2. Record inventory and follow internal procedures for recalled medications.
3. Return affected packs to the wholesaler as instructed by the supplier.

Risk assessment and context

The company that initiated this recall has stated there is no immediate risk to patients from the specific folic acid product in question. That assessment is based on the nature of the detected deviation and internal testing. Still, recalls exist to preserve high quality standards and to prevent any potential issues from reaching patients.

How this recall compares to others

Not all recalls carry the same level of danger. For example, some recent recalls targeted tablet quality attributes such as breaking hardness; manufacturers in those cases sometimes advised that intact tablets could still be taken as prescribed. Other recalls of dietary supplements have been due to contamination with heavy metals, pesticides, or unauthorized pharmacologically active substances, which can pose more serious health risks.

• Medication recall due to minor specification deviations: often a quality control action with low immediate patient risk.
• Recall due to contamination with toxic substances (lead, pesticides): higher potential health consequences — seek medical advice if exposed.
• Recall due to missing or wrong active ingredient or dangerous impurities: requires immediate action and medical assessment.

Based on multiple reports and the reviewed sources, there is consistent information that the folic acid recall described here does not present an acute safety risk. However, patients and consumers should still follow the recommended steps to verify batches and follow pharmacy guidance.

What patients and consumers should do

If you have a pack of folic acid 5 mg tablets, take the following practical steps to stay safe and informed. These steps apply to medication recalls in general and help you act quickly and sensibly.

1. Check the pack: Look for the PZN 18293103, pack size N3, and the lot/batch number on your box or blister.
2. Compare numbers: If your batch number matches the recall information provided by your pharmacy or local health authority, set the pack aside and do not dispose of it yourself.
3. Do NOT stop your medication without advice: Continue taking prescribed medications unless a health professional tells you otherwise.
4. Contact your pharmacy: Return affected packs or ask the pharmacy to check and exchange the medication as instructed. Pharmacies are the primary contact point for returns and replacement.
5. Seek medical advice if concerned: If you think you have experienced an adverse reaction or have health concerns after taking a recalled product, contact your doctor or local health services.
6. Keep documentation: Save receipts, labels or photos of the product and batch number in case further follow‑up is needed.

General consumer advice for dietary supplements and other products involved in recalls is to consult a healthcare professional if you have taken a recalled product and feel unwell. This same cautious approach applies even when a recall notice indicates a low patient risk.

Guidance for pharmacies and healthcare professionals

Pharmacies and healthcare professionals play a key role in managing medication recalls. Clear communication, accurate inventory checks, and timely returns to the wholesaler or supplier help protect patients and maintain trust in the medication supply.

Steps for pharmacies and clinicians: identify affected packs, quarantine them, inform patients who recently received affected batches when appropriate, follow supplier return procedures, and document all actions. If a patient reports symptoms potentially related to a product, provide clinical assessment and report adverse events through the usual pharmacovigilance channels.

Key takeaways

Medication recalls are precautionary safety measures. For this folic acid 5 mg recall (PZN 18293103, N3), the manufacturer indicates a low immediate patient risk, but affected batches should be returned by the stated deadline. Check your lot number, contact your pharmacy for verification or exchange, and consult a healthcare professional if you have health concerns after taking any recalled product.

Remember the general principles: always verify product batch numbers if you hear about a recall, do not stop prescribed treatment without professional advice, and seek medical help if you experience symptoms after taking a recalled or suspect product.